Quantcast

Latest AMD Stories

2014-06-12 23:09:39

Ophthalmologist Michael Tracy, MD of Carlsbad Eye Care describes new findings on potential eye dangers. San Diego, CA (PRWEB) June 12, 2014 A recent study by the American Academy of Ophthalmology has found a link between age-related macular degeneration (AMD) and medications for managing high blood pressure. According to the study, vasodilators are associated with a nearly 75% greater risk of developing AMD or other vision-threatening diseases. Carlsbad ophthalmologist Dr. Michael Tracy...

2014-06-11 04:21:59

TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA(®) (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). The EMA submission is based on the positive Phase 3 VIBRANT trial, a double-masked,...

2014-06-05 12:30:20

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/medical_devices/ophthalmic_devices_diagnostics_surgical_equipment_global_markets.html INTRODUCTIONSTUDY GOALS AND OBJECTIVESThis BCC report, Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets, provides a comprehensive description of conditions and diseases that...

2014-05-28 16:24:35

Major population study finds vasodilators may raise likelihood of age-related macular degeneration SAN FRANCISCO, May 28, 2014 /PRNewswire-USNewswire/ -- There may be a connection between taking vasodilators and developing early-stage age-related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older,[1] according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology....

2014-05-08 09:24:07

Researchers have found that, contrary to previous clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. The investigators used a strategy called "treat and extend" to conduct the study, in which the frequency of office visits and injections were tailored to each patient's...

2014-04-24 08:35:50

Renowned ophthalmic expert to provide critical guidance to MacuLogix HUMMELSTOWN, Pa., April 24, 2013 /PRNewswire/ -- MacuLogix, Inc., a pioneer in the early detection and tracking of age-related macular degeneration (AMD), today announced the appointment of Joan W. Miller, MD FARVO as a Clinical Advisor. Dr. Miller will provide MacuLogix with guidance on the development and commercialization of the Company's AdaptDx®, an advanced dark adaptometer used by eye care physicians to...

2014-04-22 12:30:18

- Proceeds will Further Strengthen Avalanche's Proprietary BioFactoryTM Platform and Advance Clinical Program in Wet Age-Related Macular Degeneration - MENLO PARK, Calif., April 22, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc, a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the successful completion of a $55 million Series B financing. New investors were led by Venrock, and...

2014-04-16 08:32:56

William Greene, MD, Appointed Chief Executive Officer SOUTH SAN FRANCISCO, Calif. and ATLANTA, April 16, 2014 /PRNewswire/ -- Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic's lead clinical-stage program is a novel recombinant human chimeric...

2014-04-15 23:16:08

When people of any age are confined to the house due to mobility & health issues, they generally have limited opportunities to socialize with those outside the home. The new Adult Mobility Device can provided them with a comfortable, adjustable ride, while protecting them from harsh weather conditions or excessive sun. Los Angeles, California (PRWEB) April 14, 2014 The adjustable Adult Mobility Device has a modern, high-tech design and is fully adjustable. The AMD has large wheels in...

2014-04-08 23:23:45

AMD Radeon™ R9 295X2 Graphics Card Engineered for Ultimate Performance San Jose, CA (PRWEB) April 08, 2014 Asetek®, the world’s leading supplier of computer liquid cooling solutions, today announced that its liquid cooling technology will be used to cool AMD’s latest flagship graphics card. The new AMD Radeon™ R9 295X2 is the world’s fastest graphics card. Boasting 8 gigabytes of memory and over 11 teraflops of computing power, the AMD Radeon™ R9 295X2 graphics card is...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'